arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

download Export Data

Omada Health, Inc.

OMDA

$20.68 ▼ -0.68 (-3.21%) at close

12 Visible periods

29 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Weak

Moderately Bearish

auto_awesome

Analytical Summary

Omada Health, Inc. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). Investors should exercise caution and monitor for improvement in key metrics.

Market Cap $1.2B

Dividend Yield —

Revenue Growth 43.1% ↗

Op. Margin 4.0% ↗

ROIC 1.4% ↗

FCF / Share $0.06 ↗

Trailing P/E 229.8x

Price / Book 5.0x

FCF Yield 0.3%

Debt / Equity —

info Valuation on last close. End-of-day price, Sep 23, 2026.

12-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$87.83M

↑ +43.1% —

Net Income Profit after all expenses

$-2.97M

↑ +68.6% —

Operating Margin Operating profit as % of sales

4.0%

↑ +166.0% 20th

FCF / Share Free cash flow per share

$0.06

↑ +132.0% —

Long-Term Debt Long-term obligations

$0.00

— —

trending_up

Bullish Indicators

Debt to EquityDebt to Equity is in the top quartile (lower is better)

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Returns

Financial Health ↑

Cash Quality

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Revenue Growth YoY (%)	43.1% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+439%)	42.0% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+425%)	58.1% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+626%)	49.5% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+518%)	48.9% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+511%)	—	—	—	—	—	—	—
EPS Growth YoY (%)	N/M	95.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	94.9% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	82.9% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—
Net Income Growth YoY (%)	68.6% Excellent ↑ Excellent Improving Year-over-year change in net income	68.6% Excellent ↑ Excellent Improving Year-over-year change in net income	N/M	50.2% Excellent Excellent Year-over-year change in net income	50.2% Excellent Excellent Year-over-year change in net income	—	—	—	—	—	—	—
FCF Growth YoY (%)	—	89.9% Excellent Excellent Year-over-year change in free cash flow	—	32.3% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Operating Margin (%) (%)	4.0% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-73%)	-6.1% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-141%)	4.3% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-71%)	-3.7% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-125%)	-7.1% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-147%)	-15.3% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-202%)	-14.8% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-199%)	-18.7% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-225%)	-24.4% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-262%)	—	—	—
Effective Tax Rate (%) (%)	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—
Profit Margin (%) (%)	-3.4% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-128%)	-3.8% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-132%)	6.8% Caution ↑ Caution Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-43%)	-13.9% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-216%)	-15.4% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-228%)	-17.2% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-243%)	-17.2% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-243%)	-41.7% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-447%)	-46.0% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-484%)	—	—	—
FCF Margin (%) (%)	4.4% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-15.3% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	27.9% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	14.1% Fair ↑ Fair Improving Free cash flow as a percentage of revenue Optimal: > 10%	—	-29.9% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-13.9% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	2.2% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—
FCF / Net Income (x)	-1.30x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	4.01x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	4.11x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	-1.02x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	—	1.74x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	-0.05x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Return on Invested Capital (%)	1.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-2.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	1.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-1.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-1.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	2.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	2.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	2.2% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	2.7% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—
Return on Capital (%) (%)	1.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-1.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	1.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-0.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-1.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	-4.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—
Return on Common Equity (%) (%)	-1.2% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-108%)	-1.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-108%)	2.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-85%)	-4.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-129%)	-4.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-129%)	2.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-84%)	2.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-86%)	5.0% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-67%)	5.1% Caution Caution Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-66%)	—	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Debt to Equity (x)	—	—	0.00x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	0.00x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	0.14x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-77%)	—	-0.08x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-113%)	—	—	—	—	—
Interest Coverage (x)	295.75x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	-265.61x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	-4.22x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	—	-9.37x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-7.61x Weak Weak Operating income divided by interest expense Optimal: > 5x	-8.71x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—
Net Debt (USD)	$-221.71M	$-211.76M	$-222.04M	$-198.63M	$-193.18M	—	$-46.62M	—	—	—	—	—
Debt / EBITDA (x)	—	—	0.00x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.00x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-6.90x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	-5.11x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Revenue per Share (USD)	$1.47	$1.32	—	$1.18	$2.79	$6.67	—	$5.84	$5.39	—	—	—
Basic EPS, GAAP (USD)	$0.09	$-0.05	$0.26	$-0.06	$-0.24	$-1.15	$-1.02	$-1.18	$-1.40	—	—	—
Free Cash Flow per Share (USD)	$0.06	$-0.20	—	$0.17	—	$-1.99	—	$0.13	—	—	—	—
Book Value per Share (USD)	$4.17	$3.95	$3.93	$3.75	$3.74	$-47.33	$-47.13	$-48.76	$-48.82	—	—	—
Tangible Book Value per Share (USD)	$3.93	$3.70	$3.66	$3.48	$3.45	$-47.33	$-49.27	$-48.76	$-48.82	—	—	—
Basic Weighted Avg Shares (shares)	59.69M	58.92M	—	57.66M	21.97M	8.24M	—	7.79M	7.65M	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Working Capital (USD)	$219.43M	$200.75M	$197.21M	$184.78M	$213.12M	—	$59.11M	—	—	—	—	—
LT Debt (USD)	—	—	$0.00	$0.00	$29.97M	—	$29.77M	—	—	—	—	—
Total Equity (USD)	$252.74M	$234.12M	$229.68M	$217.35M	$214.21M	$-390.05M	$-384.40M	$-379.77M	$-373.40M	$-365.21M	$-350.11M	$-293.17M

📋 What is driving earnings? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Sales/Revenue/Turnover (USD)	$87.83M	$78.05M	$75.85M	$68.03M	$61.37M	$54.96M	$47.98M	$45.52M	$41.21M	—	—	—
Depreciation Expense (USD)	$1.58M	$1.51M	$1.45M	$1.36M	—	$1.33M	$1.28M	$1.23M	—	—	—	—
Net Income, GAAP (USD)	$-2.97M	$-2.97M	$5.16M	$-9.45M	$-9.45M	$-9.45M	$-8.25M	$-18.97M	$-18.97M	—	—	—
Operating Cash Flow (USD)	$4.01M	$-11.83M	$21.38M	$10.13M	—	$-16.12M	$-6.49M	$1.06M	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 4 years · 12 quarters

Omada Health, Inc.

Analytical Summary

12-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare OMDA with peers